| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 10.75▼ | 10.75▼ | 10.73▲ | 10.70▼ | 10.71▼ |
| MA10 | 10.73▲ | 10.73▲ | 10.73▲ | 10.71▼ | 10.74▼ |
| MA20 | 10.75▼ | 10.75▼ | 10.75▼ | 10.70▲ | 10.74▼ |
| MA50 | 10.70▲ | 10.69▲ | 10.69▲ | 10.74▼ | 10.68▲ |
| MA100 | 10.66▲ | 10.62▲ | 10.62▲ | 10.73▼ | N/A |
| MA200 | 10.52▲ | N/A | N/A | 10.69▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.005▼ | -0.006▼ | 0.002▲ | -0.012▼ |
| RSI | 50.134▲ | 51.226▲ | 51.391▲ | 46.316▼ | 48.442▼ |
| STOCH | 83.611▲ | 64.257 | 50.368 | 9.524▼ | 22.917 |
| WILL %R | -29.167 | -50.000 | -50.000 | -71.429 | -82.143▼ |
| CCI | -7.706 | -12.357 | -18.667 | -26.492 | -126.687▼ |
|
Thursday, November 05, 2026 04:00 PM
Oaktree Acquisition Corp. III Life Sciences is trading at $10.70 per share. As of the most recent reporting period, Oaktree Acquisition Corp. III Life Sciences reported total debt of $11.82K. How much ...
|
|
Friday, October 09, 2026 05:58 AM
Oaktree Acquisition Corp. III Life Sciences Cl A stock grades by Barron's. View OACC fundamental and sentiment analysis powered by MarketGrader.
|
|
Friday, October 09, 2026 05:58 AM
Oaktree Acquisition Corp. III Life Sciences Cl A stock grades by Barron's. View OACC fundamental and sentiment analysis powered by MarketGrader.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/11/26 | 10.70 | 10.70 | 10.70 | 10.70 | 0 |
| 12/11/26 | 10.70 | 10.70 | 10.70 | 10.70 | 0 |
| 11/11/26 | 10.70 | 10.70 | 10.70 | 10.70 | 0 |
| 10/11/26 | 10.70 | 10.70 | 10.70 | 10.70 | 0 |
| 09/11/26 | 10.70 | 10.70 | 10.70 | 10.70 | 0 |
| 06/11/26 | 10.70 | 10.70 | 10.70 | 10.70 | 0 |
| 05/11/26 | 10.70 | 10.70 | 10.70 | 10.70 | 825 |
| 04/11/26 | 10.72 | 10.72 | 10.72 | 10.72 | 0 |
| 03/11/26 | 10.72 | 10.72 | 10.72 | 10.72 | 0 |
| 02/11/26 | 10.75 | 10.75 | 10.72 | 10.72 | 1,228 |
|
|
||||
|
|
||||
|
|